Two stocks in Healthcare
AstraZeneca vs Oxford Nanopore Technologies: profit, growth, debt and price compared
Oxford Nanopore Technologies is stronger on 3 of 6 figures: sales growth, debt and price trend. AstraZeneca is stronger on 2: profit margin and price for its expected profit.
Save both stocks to your watchlist and revisit their latest fundamentals.
| AstraZenecaAZN.L | Oxford Nanopore TechnologiesONT.L | |
|---|---|---|
| Net margin | Stronger: 17.7% | −51.7% |
| Revenue growth, past year | +6.70% | Stronger: +10.50% |
| Debt to equity | 66.2% | Stronger: 9.9% |
| Forward P/E | Stronger: 16.1× | Loss |
| Dividend yield | 1.73% | — |
| Analysts | Buy · 22 | Buy · 12 |
| From its 200-day average | +5.0% | Stronger: +22.8% |
Share price over the past year
- AstraZeneca0.0%
- Oxford Nanopore Technologies+58.4%
20 Nov 202518 Nov 2026
AstraZeneca or Oxford Nanopore Technologies: which is stronger?
- AZN.L
Which is more profitable?
AstraZeneca keeps more of each sale as profit: 17.7% against −51.7%.
- ONT.L
Which is growing its sales faster?
Oxford Nanopore Technologies is growing its sales faster: +10.50% over the past year, against +6.70%.
- ONT.L
Which has borrowed less?
Oxford Nanopore Technologies has borrowed less: its debt is 9.9% of what its shareholders own, against 66.2% for AstraZeneca.
- AZN.L
Which costs less for the profit it is expected to make?
AstraZeneca is expected to make a profit over the next year, where Oxford Nanopore Technologies is expected to make a loss.
Which pays more in dividends?
AstraZeneca pays 1.73% a year in dividends for what a share costs, where Oxford Nanopore Technologies pays none.
Which do analysts rate higher?
Analysts rate both the same: Buy.
- ONT.L
Which is in the stronger price trend?
Oxford Nanopore Technologies' price is in the stronger trend: 22.8% above its 200-day average, against 5.0% above.
What each company does
AZN.LAstraZeneca
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
Reports results on 9 February 2027
ONT.LOxford Nanopore Technologies
Oxford Nanopore Technologies plc researches, develops, manufactures, and commercializes DNA and RNA sequencing technology.
Reports results on 3 March 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.